Resultados de búsqueda - Veerapathran, Anandharaman
- Mostrando 1 - 12 Resultados de 12
-
1
-
2
Evaluation of Wuchereria bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis por Veerapathran, Anandharaman, Dakshinamoorthy, Gajalakshmi, Gnanasekar, Munirathinam, Reddy, Maryada Venkata Rami, Kalyanasundaram, Ramaswamy
Publicado 2009Texto -
3
-
4
Cloning and characterization of high mobility group box protein 1 (HMGB1) of Wuchereria bancrofti and Brugia malayi por Thirugnanam, Sivasakthivel, Munirathinam, Gnanasekar, Veerapathran, Anandharaman, Dakshinamoorthy, Gajalakshmi, Reddy, Maryada V., Ramaswamy, Kalyanasundaram
Publicado 2012Texto -
5
-
6
-
7
HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease por Li, Jun, Heinrichs, Jessica, Haarberg, Kelley, Semple, Kenrick, Veerapathran, Anandharaman, Liu, Chen, Anasetti, Claudio, Yu, Xue-Zhong
Publicado 2015Texto -
8
Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease por Veerapathran, Anandharaman, Pidala, Joseph, Beato, Francisca, Betts, Brian, Kim, Jongphil, Turner, Joel G., Hellerstein, Marc K., Yu, Xue-Zhong, Janssen, William, Anasetti, Claudio
Publicado 2013Texto -
9
T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for Conversions Using Reproducibility Data por Veerapathran, Anandharaman, Joshi, Rajnish, Goswami, Kalyan, Dogra, Sandeep, Moodie, Erica E. M., Reddy, M. V. R., Kalantri, Shriprakash, Schwartzman, Kevin, Behr, Marcel A., Menzies, Dick, Pai, Madhukar
Publicado 2008Texto -
10
CD4(+) T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response por Betts, Brian C., Sagatys, Elizabeth M., Veerapathran, Anandharaman, Lloyd, Mark C., Beato, Francisca, Lawrence, Harshani R., Yue, Binglin, Kim, Jongphil, Sebti, Said M., Anasetti, Claudio, Pidala, Joseph
Publicado 2015Texto -
11
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T(reg) and antitumor CTL function por Betts, Brian C., Veerapathran, Anandharaman, Pidala, Joseph, Yang, Hua, Horna, Pedro, Walton, Kelly, Cubitt, Christopher L., Gunawan, Steven, Lawrence, Harshani R., Lawrence, Nicholas J., Sebti, Said M., Anasetti, Claudio
Publicado 2017Texto -
12
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation por Betts, Brian C., Bastian, David, Iamsawat, Supinya, Nguyen, Hung, Heinrichs, Jessica L., Wu, Yongxia, Daenthanasanmak, Anusara, Veerapathran, Anandharaman, O’Mahony, Alison, Walton, Kelly, Reff, Jordan, Horna, Pedro, Sagatys, Elizabeth M., Lee, Marie C., Singer, Jack, Chang, Ying-Jun, Liu, Chen, Pidala, Joseph, Anasetti, Claudio, Yu, Xue-Zhong
Publicado 2018Texto